Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving blood clotting factor
Reexamination Certificate
2006-02-07
2006-02-07
Gitomer, Ralph (Department: 1651)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving blood clotting factor
C435S007100, C435S975000
Reexamination Certificate
active
06994983
ABSTRACT:
Kits are provided that can be used to determine a thromboxane B2metabolite level and a creatinine level in a biological sample, particularly a human urine sample. This information can be used to optimize aspirin dosage in a patient. The present invention further includes calibrant preparations. In some embodiments, these calibrants comprise urine, particularly human urine that is identified in repeated trials to provide a consistent and reproduceable level of thromboxane B2metabolite. As such, they function as control preparations that reduce error from intra-assay sampling measurements.
REFERENCES:
patent: 5538901 (1996-07-01), Law et al.
patent: 64-13459 (1989-01-01), None
Takasaki, W. Enzyme Immunoassay of Human Plasma 11-Dehydrothromboxane B2. Thrombosis Research vol. 63, 331-341, 1991.
Pemeby C. Optimization of an Enzyme Immunoassay for 11-Dehydrothromboxane B2 in Urine: Comparison with GC-MS. Thrombosis Research vol. 96, 427-436, Jun. 15, 1999.
Williams S. Better increase in Fibrin Gel Porosity by Low Dose Than Intermediate Dose Actylsalicyic Acid. European Heart J 19(11)1666-1672, 1998.
Juul-Moler S., Edvardsson N., Jahnmatz B., et al., Lancet 1992; 340:1421.
ISIS-2 Collaborative Group; ISIS-2, Lancet 1988; 2: 349.
The Dutch TIA Study Group, N. Engl. J. Med. 1991; 325:1261.
Hirsh J., Dalen J.E., Fuster V., Harker L.B., Patrono C., Roth G., Chest 1995; 108 Suppl.: 247s.
International Stroke Trial Collaborative Group, Lancet 1997; 349: 1569.
CAST (Chinese Acute Stroke Trial) Collaborative Group, Lancet 1997; 349: 1641.
The Medical Research Council's General Practice Research Framework, Lancet 1998;351:233.
Hansson L., Zanchatti A., Carruthers S.G., et al., Lancet 1998; 351:1755.
Fitch L.L., Buchwald H., Matts J.P., Am. Heart J. 1995; 129: 656.
Antiplatelet Trialists' Collaboration, BMJ 1994; 308: 81.
Hennekens C.H., Peto R., Hutchinson G.B., et al., N. Engl. J. Med. 1988; 318:923.
Manson J.E., Stampfer MI, Colditz G.A., et al., JAMA 1991; 266: 521.
Ridker P.M., Manson J.E., Buring J.E., Muller J.E., Hennekens C.H., Circulation 1990;82:897.
Buring J.E., Hennekens C.H., J. Myocardial Ischemia 1992; 4: 27.
Roderick P.J., Wilkes H.C., Meade T. W., Br. J. Clin. Pharmacol 1993; 35: 219.
Petroski D., Lancet 1997; 349: 430.
Peto R., Gray R., Collins R., et al., BMJ 1988; 296: 313.
Kronmal RA., Hart RG., Manolio T.A., Stroke 1998; 29: 887.
He J., Whelton P.K., Vu B., Klag MI, JAMA 1998; 280:1930.
Patrona C., Coller B., Dalen J., et al., Chest 1998; 114 Suppl:470s.
Helgason C.M., Hoff J.A, Kindos G.T., Barce L.D., Stroke 1993; 24:1458.
Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., Hennekens C.H. Circulation 82(3) 1990 p 897-899.
Wu K.K., Hoak J.C., Lancet 11;1974:924.
Trip M.D., Cats V.M., Van Capelle F.J.L., Vreeken J., New Engl. J. Med. 1990, 322:1549.
Helgason C.M., Bolin K.M., Hoff J.A., et al., Stroke 1994; 25: 2331.
Pappas J.M., Westengard J.C., Bull B.S., Arch. Path. Lab. Med. 1994; 118: 801.
Mueller M.R., Salat A., Stangl P., Thromb. Haemost 1997; 78: 1003.
Grotemeyer KH., Scharafinski H.W., Husstedt I.W., Thrombos. Res. 1993; 71:397.
Komiya T., Kudo M., Urabe T., Mizuno Y., Stroke 1994; 25: 2337.
Israels L.G., Activation of Permeabilized Platelets by Inosltol-1, 4,5-Triphosphate, Thrombus Res 40 499-509 1985.
Rifkin R.M., Effect of Dipyridamole and RA 233 on Human Platelet Function in Vitro Thrombus D. H 1978 vol. 29 694-700.
Vane J.R., Botting RM., Semin. Arthr. Rheum. 1997; 25 Suppl. 1: 2.
Lawson JA., Patrono C., Ciabattone G., et al., Anal. Biocem. 1986, 155: 198.
Schror K., Semin. Thrombos. Hemostas. 1997; 23: 349.
Weber A.A., Zimmennann K.C., Meyer-Kirchrath J., Schror K., Lancet 1999;353: 900.
Pedersen A.K, Fitzgerald G.A., New Engl. J Med. 1984; 311: 1206.
Schmidt E.B., Dyerberg J., Drugs 1994; 47: 405.
Weber P., Dendich A., Machlin L.J., Nutr. 1997; 13: 450.
O'neil C.K., Avila J.R., Fetrow C.W., Nursing 1999; 58.
Jannsen P.L.T.M.K., Akkeman J.-W.N., Hoilman P.C.H., Van Staveren W.A., Zwaginga J-J, Katan M.B., Eur. J. Clin. Nutr. 1995; 49:365.
Beving H., Eksborg S., Malmgren R.S., et al., Thrombos. Res. 1994; 74:39.
Buerke M., Pittroff W., Meyer J., Darius H., Am. Heart J. 1995; 130:465.
May J.A., Heptinstall S., Cole A.T., Hawkey C.J., Thrombos. Res. 1997; 88: 183.
Samuelsson B., Granstrom E., Green K., et al., Ann. Rev. Biochem. 1975;44:669.
Catella F., Fitzgerald G.A., Thrombos. Res. 1987; 47:647.
Catella F., Healy D., Lawson J.A., et al., Proc. Natl. Acad. Sci. USA 1986; 83: 5861.
Van Kooten F., Ciabattoni G., Koudstaal P.J., Dippel W.J., Patrono C., Stroke 1999;30:546.
Lellouche F., Fradin A., Fitzgerald G., et al., Prostaglandins 1990; 40: 297.
Baker & McKenzie LLP
Esoterix, Inc. Coagulation
Gitomer Ralph
LandOfFree
Kits for determination of thromboxane B 2 metabolite and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Kits for determination of thromboxane B 2 metabolite and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Kits for determination of thromboxane B 2 metabolite and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3694056